Protein tyrosine phosphatase σ in proteoglycan-mediated neural regeneration regulation

Molecular Neurobiology

Volumn 47, Issue 1, 2013, Pages 220-227

  Chien, Pham Ngoc ^a   Ryu, Seong Eon ^a  

^a Hanyang University   (South Korea)

Author keywords

Chondroitin sulfate; Heparan sulfate; Neural regeneration; Protein tyrosine phosphatase ; Proteoglycan; Structure and function

Indexed keywords

CHONDROITIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SIGMA; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME STRUCTURE; GENETIC ANALYSIS; MOUSE; NERVE GROWTH; NERVE REGENERATION; NONHUMAN; OLIGOMERIZATION; PROTEIN DOMAIN; REVIEW; SPINAL GANGLION;

EID: 84872502053     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8346-x     Document Type: Review

References (74)

1. Tonks NK (2006) Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 7(11):833-846. doi: 10.1038/nrm2039
2. Tabernero L, Aricescu AR, Jones EY, Szedlacsek SE (2008) Protein tyrosine phosphatases: structure-function relationships. FEBS J 275(5):867-882. doi: 10.1111/j.1742-4658.2008.06251.x
3. Alonso A, Sasin J, Bottini N, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T (2004) Protein tyrosine phosphatases in the human genome. Cell 117(6):699-711. doi: 10.1016/j.cell.2004.05.018
4. Chagnon MJ, Uetani N, Tremblay ML (2004) Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases. Biochem Cell Biol 82(6):664-675. doi: 10.1139/o04-120
5. Johnson KG, Van Vactor D (2003) Receptor protein tyrosine phosphatases in nervous system development. Physiol Rev 83(1):1-24. doi: 10.1152/physrev.00016. 2002
6. Pulido R, Serra-Pages C, Tang M, Streuli M (1995) The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1. Proc Natl Acad Sci U S A 92(25):11686-11690
7. Persson C, Sjoblom T, Groen A, Kappert K, Engstrom U, Hellman U, Heldin CH, den Hertog J, Ostman A (2004) Preferential oxidation of the second phosphatase domain of receptor-like PTP-alpha revealed by an antibody against oxidized protein tyrosine phosphatases. Proc Natl Acad Sci U S A 101(7):1886-1891. doi: 10.1073/pnas.0304403101
8. van der Wijk T, Overvoorde J, den Hertog J (2004) H2O2-induced intermolecular disulfide bond formation between receptor protein-tyrosine phosphatases. J Biol Chem 279(43):44355-44361. doi: 10.1074/jbc.M407483200
9. Meathrel K, Adamek T, Batt J, Rotin D, Doering LC (2002) Protein tyrosine phosphatase sigma-deficient mice show aberrant cytoarchitecture and structural abnormalities in the central nervous system. J Neurosci Res 70(1):24-35. doi: 10.1002/jnr.10382
10. Elchebly M, Wagner J, Kennedy TE, Lanctot C, Michaliszyn E, Itie A, Drouin J, Tremblay ML (1999) Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase sigma. Nat Genet 21(3):330-333. doi: 10.1038/6859
11. Wallace MJ, Batt J, Fladd CA, Henderson JT, Skarnes W, Rotin D (1999) Neuronal defects and posterior pituitary hypoplasia in mice lacking the receptor tyrosine phosphatase PTPsigma. Nat Genet 21(3):334-338. doi: 10.1038/6866
12. Uetani N, Kato K, Ogura H, Mizuno K, Kawano K, Mikoshiba K, Yakura H, Asano M, Iwakura Y (2000) Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice. EMBO J 19(12):2775-2785. doi: 10.1093/emboj/19.12.2775
13. Uetani N, Chagnon MJ, Kennedy TE, Iwakura Y, Tremblay ML (2006) Mammalian motoneuron axon targeting requires receptor protein tyrosine phosphatases sigma and delta. J Neurosci 26(22):5872-5880. doi: 10.1523/JNEUROSCI.0386-06.2006
14. Paul S, Lombroso PJ (2003) Receptor and nonreceptor protein tyrosine phosphatases in the nervous system. Cell Mol Life Sci 60(11):2465-2482. doi: 10.1007/s00018-003-3123-7
15. Yeo TT, Yang T, Massa SM, Zhang JS, Honkaniemi J, Butcher LL, Longo FM (1997) Deficient LAR expression decreases basal forebrain cholinergic neuronal size and hippocampal cholinergic innervation. J Neurosci Res 47(3):348-360
16. Van Lieshout EM, Van der Heijden I, Hendriks WJ, Van der Zee CE (2001) A decrease in size and number of basal forebrain cholinergic neurons is paralleled by diminished hippocampal cholinergic innervation in mice lacking leukocyte common antigen-related protein tyrosine phosphatase activity. Neuroscience 102(4):833-841
17. Aricescu AR, McKinnell IW, Halfter W, Stoker AW (2002) Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma. Mol Cell Biol 22(6):1881-1892
18. Theocharis AD, Skandalis SS, Tzanakakis GN, Karamanos NK (2010) Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J 277(19):3904-3923. doi: 10.1111/j.1742-4658.2010.07800.x
19. Schaefer L, Schaefer RM (2010) Proteoglycans: from structural compounds to signaling molecules. Cell Tissue Res 339(1):237-246. doi: 10.1007/s00441-009-0821-y
20. Rossi A, Kaitila I, Wilcox WR, Rimoin DL, Steinmann B, Cetta G, Superti-Furga A (1998) Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production. Matrix Biol 17(5):361-369
21. Iozzo RV (1998) Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67:609-652. doi: 10.1146/annurev.biochem.67.1.609
22. Kwok JC, Afshari F, Garcia-Alias G, Fawcett JW (2008) Proteoglycans in the central nervous system: plasticity, regeneration and their stimulation with chondroitinase ABC. Restor Neurol Neurosci 26(2-3):131-145
23. Silver J, Miller JH (2004) Regeneration beyond the glial scar. Nat Rev Neurosci 5(2):146-156. doi: 10.1038/nrn1326
24. Rhodes KE, Fawcett JW (2004) Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS? J Anat 204(1):33-48. doi: 10.1111/j.1469-7580.2004.00261.x
25. Cafferty WB, Bradbury EJ, Lidierth M, Jones M, Duffy PJ, Pezet S, McMahon SB (2008) Chondroitinase ABC-mediated plasticity of spinal sensory function. J Neurosci 28(46):11998-12009. doi: 10.1523/JNEUROSCI.3877-08.2008
26. Houle JD, Tom VJ, Mayes D, Wagoner G, Phillips N, Silver J (2006) Combining an autologous peripheral nervous system bridge and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J Neurosci 26(28):7405-7415. doi: 10.1523/JNEUROSCI.1166-06.2006
27. Tester NJ, Howland DR (2008) Chondroitinase ABC improves basic and skilled locomotion in spinal cord injured cats. Exp Neurol 209(2):483-496. doi: 10.1016/j.expneurol.2007.07.019
28. Yamaguchi Y (2001) Heparan sulfate proteoglycans in the nervous system: their diverse roles in neurogenesis, axon guidance, and synaptogenesis. Semin Cell Dev Biol 12(2):99-106. doi: 10.1006/scdb.2000.0238
29. Van Vactor D, Wall DP, Johnson KG (2006) Heparan sulfate proteoglycans and the emergence of neuronal connectivity. Curr Opin Neurobiol 16(1):40-51. doi: 10.1016/j.conb.2006.01.011
30. Jen YH, Musacchio M, Lander AD (2009) Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis. Neural Dev 4:33. doi: 10.1186/1749-8104-4-33
31. Shen Y, Tenney AP, Busch SA, Horn KP, Cuascut FX, Liu K, He Z, Silver J, Flanagan JG (2009) PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 326(5952):592-596. doi: 10.1126/science.1178310
32. Coles CH, Shen Y, Tenney AP, Siebold C, Sutton GC, Lu W, Gallagher JT, Jones EY, Flanagan JG, Aricescu AR (2011) Proteoglycan-specific molecular switch for RPTPsigma clustering and neuronal extension. Science 332(6028):484-488. doi: 10.1126/science.1200840
33. Hill JJ, Jin K, Mao XO, Xie L, Greenberg DA (2012) Intracerebral chondroitinase ABC and heparan sulfate proteoglycan glypican improve outcome from chronic stroke in rats. Proc Natl Acad Sci U S A 109(23):9155-9160. doi: 10.1073/pnas.1205697109
34. Dunah AW, Hueske E, Wyszynski M, Hoogenraad CC, Jaworski J, Pak DT, Simonetta A, Liu G, Sheng M (2005) LAR receptor protein tyrosine phosphatases in the development and maintenance of excitatory synapses. Nat Neurosci 8(4):458-467. doi: 10.1038/nn1416
35. Rashid-Doubell F, McKinnell I, Aricescu AR, Sajnani G, Stoker A (2002) Chick PTPsigma regulates the targeting of retinal axons within the optic tectum. J Neurosci 22(12):5024-5033
36. Fry EJ, Chagnon MJ, Lopez-Vales R, Tremblay ML, David S (2010) Corticospinal tract regeneration after spinal cord injury in receptor protein tyrosine phosphatase sigma deficient mice. Glia 58(4):423-433. doi: 10.1002/glia.20934
37. McLean J, Batt J, Doering LC, Rotin D, Bain JR (2002) Enhanced rate of nerve regeneration and directional errors after sciatic nerve injury in receptor protein tyrosine phosphatase sigma knock-out mice. J Neurosci 22(13):5481-5491. doi: 20026462
38. Thompson KM, Uetani N, Manitt C, Elchebly M, Tremblay ML, Kennedy TE (2003) Receptor protein tyrosine phosphatase sigma inhibits axonal regeneration and the rate of axon extension. Mol Cell Neurosci 23(4):681-692
39. Sapieha PS, Duplan L, Uetani N, Joly S, Tremblay ML, Kennedy TE, Di Polo A (2005) Receptor protein tyrosine phosphatase sigma inhibits axon regrowth in the adult injured CNS. Mol Cell Neurosci 28(4):625-635. doi: 10.1016/j.mcn.2004.10.011
40. Haworth K, Shu KK, Stokes A, Morris R, Stoker A (1998) The expression of receptor tyrosine phosphatases is responsive to sciatic nerve crush. Mol Cell Neurosci 12(3):93-104. doi: 10.1006/mcne.1998.0707
41. Mulloy B, Forster MJ, Jones C, Davies DB (1993) N.m.r. and molecular-modelling studies of the solution conformation of heparin. Biochem J 293(Pt 3):849-858
42. Khan S, Gor J, Mulloy B, Perkins SJ (2010) Semi-rigid solution structures of heparin by constrained X-ray scattering modelling: new insight into heparin-protein complexes. J Mol Biol 395(3):504-521. doi: 10.1016/j.jmb.2009. 10.064
43. Maccarana M, Sakura Y, Tawada A, Yoshida K, Lindahl U (1996) Domain structure of heparan sulfates from bovine organs. J Biol Chem 271(30):17804-17810
44. Murphy KJ, Merry CL, Lyon M, Thompson JE, Roberts IS, Gallagher JT (2004) A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase. J Biol Chem 279(26):27239-27245. doi: 10.1074/jbc.M401774200
45. Bilwes AM, den Hertog J, Hunter T, Noel JP (1996) Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization. Nature 382(6591):555-559. doi: 10.1038/382555a0
46. Kurihara D, Yamashita T (2012) Chondroitin sulfate proteoglycans down-regulate spine formation in cortical neurons by targeting tropomyosin-related kinase B (TrkB) protein. J Biol Chem 287(17):13822-13828. doi: 10.1074/jbc.M111.314070
47. Cabelli RJ, Hohn A, Shatz CJ (1995) Inhibition of ocular dominance column formation by infusion of NT-4/5 or BDNF. Science 267(5204):1662-1666
48. Galuske RA, Kim DS, Castren E, Thoenen H, Singer W (1996) Brain-derived neurotrophic factor reversed experience-dependent synaptic modifications in kitten visual cortex. Eur J Neurosci 8(7):1554-1559
49. Tyler WJ, Pozzo-Miller LD (2001) BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses. J Neurosci 21(12):4249-4258
50. Shimada A, Mason CA, Morrison ME (1998) TrkB signaling modulates spine density and morphology independent of dendrite structure in cultured neonatal Purkinje cells. J Neurosci 18(21):8559-8570
51. Faux C, Hawadle M, Nixon J, Wallace A, Lee S, Murray S, Stoker A (2007) PTPsigma binds and dephosphorylates neurotrophin receptors and can suppress NGF-dependent neurite outgrowth from sensory neurons. Biochim Biophys Acta 1773(11):1689-1700. doi: 10.1016/j.bbamcr.2007.06.008
52. Takahashi H, Arstikaitis P, Prasad T, Bartlett TE, Wang YT, Murphy TH, Craig AM (2011) Postsynaptic TrkC and presynaptic PTPsigma function as a bidirectional excitatory synaptic organizing complex. Neuron 69(2):287-303. doi: 10.1016/j.neuron.2010.12.024
53. Siu R, Fladd C, Rotin D (2007) N-cadherin is an in vivo substrate for protein tyrosine phosphatase sigma (PTPsigma) and participates in PTPsigma-mediated inhibition of axon growth. Mol Cell Biol 27(1):208-219. doi: 10.1128/MCB.00707-06
54. Chagnon MJ, Wu CL, Nakazawa T, Yamamoto T, Noda M, Blanchetot C, Tremblay ML (2010) Receptor tyrosine phosphatase sigma (RPTPsigma) regulates, p250GAP, a novel substrate that attenuates Rac signaling. Cell Signal 22(11):1626-1633. doi: 10.1016/j.cellsig.2010.06.001
55. Kiok K, Sun H, Clancy H, Bose S, Kluz T, Wu F, Costa M (2011) Liprin-alpha4 is required for nickel induced receptor protein tyrosine phosphatase-leukocyte antigen related receptor F (RPTP-LAR) activity. PLoS One 6(8):e22764. doi: 10.1371/journal.pone.0022764
56. Almo SC, Bonanno JB, Sauder JM, Emtage S, Dilorenzo TP, Malashkevich V, Wasserman SR, Swaminathan S, Eswaramoorthy S, Agarwal R, Kumaran D, Madegowda M, Ragumani S, Patskovsky Y, Alvarado J, Ramagopal UA, Faber-Barata J, Chance MR, Sali A, Fiser A, Zhang ZY, Lawrence DS, Burley SK (2007) Structural genomics of protein phosphatases. J Struct Funct Genomics 8(2-3):121-140. doi: 10.1007/s10969-007-9036-1
57. Nam HJ, Poy F, Krueger NX, Saito H, Frederick CA (1999) Crystal structure of the tandem phosphatase domains of RPTP LAR. Cell 97(4):449-457
58. Jiang G, den Hertog J, Su J, Noel J, Sap J, Hunter T (1999) Dimerization inhibits the activity of receptor-like protein-tyrosine phosphatase-alpha. Nature 401(6753):606-610. doi: 10.1038/44170
59. Tertoolen LG, Blanchetot C, Jiang G, Overvoorde J, Gadella TW Jr, Hunter T, den Hertog J (2001) Dimerization of receptor protein-tyrosine phosphatase alpha in living cells. BMC Cell Biol 2(8)
60. Xu Z, Weiss A (2002) Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat Immunol 3(8):764-771. doi: 10.1038/ni822
61. Lee S, Faux C, Nixon J, Alete D, Chilton J, Hawadle M, Stoker AW (2007) Dimerization of protein tyrosine phosphatase sigma governs both ligand binding and isoform specificity. Mol Cell Biol 27(5):1795-1808. doi: 10.1128/MCB.00535-06
62. Fawcett JW, Asher RA (1999) The glial scar and central nervous system repair. Brain Res Bull 49(6):377-391
63. Rolls A, Shechter R, Schwartz M (2009) The bright side of the glial scar in CNS repair. Nat Rev Neurosci 10(3):235-241. doi: 10.1038/nrn2591
64. Panickar KS, Norenberg MD (2005) Astrocytes in cerebral ischemic injury: morphological and general considerations. Glia 50(4):287-298. doi: 10.1002/glia.20181
65. Biersmith BH, Hammel M, Geisbrecht ER, Bouyain S (2011) The immunoglobulin-like domains 1 and 2 of the protein tyrosine phosphatase LAR adopt an unusual horseshoe-like conformation. J Mol Biol 408(4):616-627. doi: 10.1016/j.jmb.2011.03.013
66. Fisher D, Xing B, Dill J, Li H, Hoang HH, Zhao Z, Yang XL, Bachoo R, Cannon S, Longo FM, Sheng M, Silver J, Li S (2011) Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors. J Neurosci 31(40):14051-14066. doi: 10.1523/JNEUROSCI.1737-11.2011
67. Yang T, Yin W, Derevyanny VD, Moore LA, Longo FM (2005) Identification of an ectodomain within the LAR protein tyrosine phosphatase receptor that binds homophilically and activates signalling pathways promoting neurite outgrowth. Eur J Neurosci 22(9):2159-2170. doi: 10.1111/j.1460-9568.2005.04403.x
68. Xie Y, Massa SM, Ensslen-Craig SE, Major DL, Yang T, Tisi MA, Derevyanny VD, Runge WO, Mehta BP, Moore LA, Brady-Kalnay SM, Longo FM (2006) Protein-tyrosine phosphatase (PTP) wedge domain peptides: a novel approach for inhibition of PTP function and augmentation of protein-tyrosine kinase function. J Biol Chem 281(24):16482-16492. doi: 10.1074/jbc.M603131200
69. Xie Y, Yeo TT, Zhang C, Yang T, Tisi MA, Massa SM, Longo FM (2001) The leukocyte common antigen-related protein tyrosine phosphatase receptor regulates regenerative neurite outgrowth in vivo. J Neurosci 21(14):5130-5138
70. Ketschek AR, Haas C, Gallo G, Fischer I (2012) The roles of neuronal and glial precursors in overcoming chondroitin sulfate proteoglycan inhibition. Exp Neurol 235(2):627-637. doi: 10.1016/j.expneurol.2012.03.017
71. Bonner JF, Connors TM, Silverman WF, Kowalski DP, Lemay MA, Fischer I (2011) Grafted neural progenitors integrate and restore synaptic connectivity across the injured spinal cord. J Neurosci 31(12):4675-4686. doi: 10.1523/JNEUROSCI.4130-10.2011
72. Bonner JF, Blesch A, Neuhuber B, Fischer I (2010) Promoting directional axon growth from neural progenitors grafted into the injured spinal cord. J Neurosci Res 88(6):1182-1192. doi: 10.1002/jnr.22288
73. See J, Bonner J, Neuhuber B, Fischer I (2010) Neurite outgrowth of neural progenitors in presence of inhibitory proteoglycans. J Neurotrauma 27(5):951-957. doi: 10.1089/neu.2009.1158
74. Barr AJ, Ugochukwu E, Lee WH, King ON, Filippakopoulos P, Alfano I, Savitsky P, Burgess-Brown NA, Muller S, Knapp S (2009) Large-scale structural analysis of the classical human protein tyrosine phosphatome. Cell 136(2):352-363. doi: 10.1016/j.cell.2008.11.038